This compound is a triazolopyridine derivative that serves as a pharmaceutical intermediate in the manufacturing process of Tucatinib. It is characterized by a fused ring system containing both triazole and pyridine moieties, with a ketone functional group contributing to its moderate polarity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing [1,2,4]triazolo[1,5-a]pyridin-7-ol?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-2-Pyrrolidinemethanamine dihydrochloride
pharmaceutical intermediate
3',5'-Bis-O-(4-chlorobenzoyl)-2-deoxy-5-azacytosine
pharmaceutical intermediate
2-(5-Bromo-2-fluorobenzyl)benzothiophene
pharmaceutical intermediate
(2S)-1,2,4-Piperazinetricarboxylic acid 1-(tert-butyl) 4-(9H-fluoren-9-ylmethyl) ester
pharmaceutical intermediate
3H-[1,2,4]triazolo[1,5-a]pyridin-7-one
BABOSZMRHSQJCE-UHFFFAOYSA-N
C1=CN2C(=CC1=O)N=CN2
—
Sourcing [1,2,4]triazolo[1,5-a]pyridin-7-ol?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.